1. Home
  2. BATRK vs IRON Comparison

BATRK vs IRON Comparison

Compare BATRK & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series C

BATRK

Atlanta Braves Holdings Inc. Series C

HOLD

Current Price

$40.32

Market Cap

2.5B

Sector

Industrials

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$71.65

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRK
IRON
Founded
1991
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
3.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BATRK
IRON
Price
$40.32
$71.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
13
Target Price
$58.00
$108.85
AVG Volume (30 Days)
329.5K
684.5K
Earning Date
02-25-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$723,307,000.00
N/A
Revenue This Year
$12.40
N/A
Revenue Next Year
$6.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.62
N/A
52 Week Low
$35.46
$30.82
52 Week High
$47.18
$99.50

Technical Indicators

Market Signals
Indicator
BATRK
IRON
Relative Strength Index (RSI) 57.57 29.87
Support Level $39.71 $76.19
Resistance Level $40.62 $81.90
Average True Range (ATR) 0.69 3.36
MACD 0.05 -0.51
Stochastic Oscillator 74.29 8.20

Price Performance

Historical Comparison
BATRK
IRON

About BATRK Atlanta Braves Holdings Inc. Series C

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: